ERBB2 and neoplasm: Near-infrared QD bioconjugation with anti-HER2 antibodies with the use of EDC/NHS coupling methods performed by a different study group led to successful localization of both fixed and live tumor cells, as shown on the SK-BR-3 cells, which overexpress HER2 with MCF7 as a low-HER2 control [163].